Loading company…
Toronto medical imaging company whose point-of-care devices use fluorescence to assess wounds and detect bacterial load.
Founded in 2013 and based in Toronto, Canada, MolecuLight Inc. develops a non-invasive optical technology for point-of-care wound analysis. Its devices, the MolecuLight i and MolecuLight DX, use fluorescence to detect bacterial loads and measure wound dimensions. CEO Anil Amlani leads the company as of 2024. In January 2025 it raised USD 27.5 million in venture funding from new investor Hayfin Capital Management, and its listed stage is Series C.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in